Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Clinical Lymphoma, Myeloma & Leukemia|July 19, 2025
Real-World Evidence on Outcomes and Safety of Ropeginterferon Alfa-2b in Patients With Myeloproliferative Neoplasms: A Retrospective Cohort StudyYu-Sung Chang, Chieh-Yu Liu, Yu-Wen Chen, et al.
Hematological Oncology|November 24, 2022
Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromesWan-Hsuan Lee, Chien-Chin Lin, Yu-Hung Wang, et al.
Blood Cancer Journal|July 31, 2025
A clinico-genomic prognostic model for primary myelodysplastic neoplasm in AsiaHarinder Gill, Rita Yim, Paul Lee, et al.
Blood Advances|May 17, 2021
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AMLCheng-Hong Tsai, Jih-Luh Tang, Feng-Ming Tien, et al.
Clinical Epigenetics|April 6, 2018
Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndromeMing-En Lin, Hsin-An Hou, Cheng-Hong Tsai, et al.
Pageof 7